Atorvastatin and Lisinopril
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
UNC Lineberger Comprehensive Cancer Center
Overview
Atorvastatin and Lisinopril is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Atorvastatin and Lisinopril clinical trials
Explore related
Medical disclaimer. This page summarizes research about Atorvastatin and Lisinopril for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.